Form 4: Clarivate Executive Henry Levy Reports Share Withholding

Clarivate PLC President of Life Sciences & Healthcare, Henry Levy, reported the withholding of 19,893 shares to cover tax obligations.

Summary

• Henry Levy, President of Life Sciences & Healthcare at Clarivate PLC, executed a transaction involving the withholding of 19,893 ordinary shares.
• The transaction occurred on May 1, 2026, at a price of $2.79 per share.
• The shares were withheld to satisfy tax withholding obligations related to the vesting of restricted share units.
• Following this transaction, Henry Levy maintains beneficial ownership of 983,373 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a mandatory tax-related transaction rather than a strategic shift or discretionary trading activity.

Positives

• The transaction is a routine administrative action related to tax obligations upon the vesting of equity compensation, rather than a discretionary open-market sale.

Negatives

• The transaction results in a reduction of the reporting person's direct shareholding in the company.

Risks

• None identified; this is a standard tax-related equity transaction.

Future Outlook

Not applicable; this is a retrospective disclosure of an equity transaction.

Industry Context

StockSavvy.ai notes that routine tax withholding transactions by executives are standard corporate practice and do not typically signal changes in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction aligns with standard executive compensation practices for publicly traded companies where restricted share units are subject to mandatory tax withholding upon vesting.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a standard tax-related equity settlement.

Key Dates

Keywords

Clarivate, CLVT, Insider Trading, Form 4, Equity Compensation, Tax Withholding